
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
Senior Principal Scientist (R3-R4)
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.
Eli Lilly and Company seeks a Senior Principal Scientist (R3-R4) to execute experiments on the cutting edge of pharmaceutical sciences. Support research programs for identified targets. Oversee aspects of portfolio programs independently by demonstrating laboratory expertise with biologic assays aimed at drug development (m Ab, ADC, and CD3 platforms). Perform assay development for specialized assays related to portfolio programs. Perform functional m Ab screening and profiling. Conduct evaluation of both in vitro and ex vivo assays.
Position requires a Master’s degree in Biomedical Engineering, Bioengineering, or a related field, and 2 years of experience with drug development with m Ab, ADC, and CD3 platforms. Experience must include a minimum of: 1 year of experience with phenotypic screens using human myeloid cells to identify novel immuno-oncology targets; 1 year of experience designing and implementing cellular assays to generate subsets of myeloid cells; 1 year of experience using multi-color flow cytometry, Nano String n Counter, and RASL sequencing to characterize myeloid culture systems; and 1 year of experience developing and optimizing flow cytometry, ELISA, and 32-plex Luminex based functional assays to validate the response of protein-based cancer vaccines in murine and cynomolgus models. Part-time telecommuting permitted.
Job location: New York, NY
To apply, please visit https://jobsearch.lilly.com/ and enter job requisition number R-103515 when prompted. Alternatively, please send your resume, cover letter, and a copy of the ad to: Matthew Tenaglio, Lilly Corporate Center, Indianapolis, IN 46285.
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia Network, Black Employees at Lilly, Chinese Culture Network, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinx at Lilly (OLA), PRIDE (LGBTQ+ Allies), Veterans Leadership Network (VLN), Women’s Initiative for Leading at Lilly (WILL), en Able (for people with disabilities). Learn more about all of our groups.
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is
$105,997.00 - $187,000.00 per year
Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#We Are Lilly
전체 조회수
0
전체 지원 클릭
0
전체 Mock Apply
0
전체 스크랩
0
비슷한 채용공고
Eli Lilly 소개

Eli Lilly
PublicEli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
10,001+
직원 수
US
본사 위치
$588B
기업 가치
리뷰
10개 리뷰
3.8
10개 리뷰
워라밸
3.2
보상
4.1
문화
3.7
커리어
2.8
경영진
3.9
72%
지인 추천률
장점
Excellent compensation and benefits
Supportive management and leadership
Flexible work arrangements
단점
Limited career advancement opportunities
High stress and demanding workload
Fast-paced and high-pressure environment
연봉 정보
56개 데이터
Mid/L4
Senior/L5
Mid/L4 · ADVISOR - DATA SCIENTIST - AADS
1개 리포트
$199,167
총 연봉
기본급
$153,975
주식
-
보너스
-
$199,167
$199,167
면접 후기
후기 2개
난이도
2.5
/ 5
소요 기간
14-28주
합격률
100%
경험
긍정 50%
보통 50%
부정 0%
면접 과정
1
Application Review
2
HR Screen
3
Phone/Video Interview
4
Hiring Manager Interview
5
Final Interview/Panel
6
Offer
자주 나오는 질문
Behavioral/STAR
Past Experience
Culture Fit
Industry Knowledge
Technical Knowledge
최근 소식
Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 (NYSE:LLY) - Seeking Alpha
Seeking Alpha
News
·
1w ago
Why Eli Lilly (LLY) Shares Are Trading Lower Today - StockStory
StockStory
News
·
1w ago
A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B - statnews.com
statnews.com
News
·
1w ago
Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters
Reuters
News
·
1w ago



